000 -LEADER |
fixed length control field |
00728cam a2200241Ii 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
KDUcat |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
180420s2017 fluab ob 001 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781315119878 |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
English Language |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1/9 |
100 ## - PERSONAL NAME (AUTHOR) |
Personal name |
Chow, Shein-Chung |
Relator term |
Editor |
9 (RLIN) |
55782 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Declerck, Dr. Paul |
Relator term |
Editor |
9 (RLIN) |
55783 |
|
Personal name |
Endrenyi, Laszlo |
Relator term |
Editor |
9 (RLIN) |
55784 |
245 00 - TITLE STATEMENT |
Title |
Biosimilar drug product development |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Boca Raton |
Name of publisher, distributor, etc |
CRC Press |
Date of publication, distribution, etc |
2017 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
487 p. |
Other physical details |
ill. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Biosimilar Pharmaceuticals |
9 (RLIN) |
55785 |
|
Topical term or geographic name as entry element |
Drug Approval |
9 (RLIN) |
55786 |
|
Topical term or geographic name as entry element |
Drug Evaluation |
9 (RLIN) |
55787 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
https://www.taylorfrancis.com/books/9781315119878 |
Public note |
Click here to view. |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Koha item type |
E-books |